153 related articles for article (PubMed ID: 29658472)
21. Newborn screening shows a high incidence of sickle cell anemia in Central India.
Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
[TBL] [Abstract][Full Text] [Related]
22. Nurses are key to sickle cell screening.
Anionwu E
Nurs Times; 2004 Aug 31-Sep 6; 100(35):18. PubMed ID: 15471262
[No Abstract] [Full Text] [Related]
23. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns.
Tshilolo L; Aissi LM; Lukusa D; Kinsiama C; Wembonyama S; Gulbis B; Vertongen F
J Clin Pathol; 2009 Jan; 62(1):35-8. PubMed ID: 19103857
[TBL] [Abstract][Full Text] [Related]
24. Screening for sickle-cell disease in Brazil.
Serjeant GR
Lancet; 2000 Jul; 356(9224):168-9. PubMed ID: 10963278
[No Abstract] [Full Text] [Related]
25. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
[TBL] [Abstract][Full Text] [Related]
26. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
[No Abstract] [Full Text] [Related]
27. Sickle cell screening in Europe: the time has come.
Shook LM; Ware RE
Br J Haematol; 2018 Nov; 183(4):534-535. PubMed ID: 30430539
[No Abstract] [Full Text] [Related]
28. [Sickle cell disease neonatal screening. First evaluation].
Mbodj M; Ndoye O; Diarra M; Mbaye BN; Sow Toure H; Diouf L; Gassama Seck S; Dhondt JL; Farriaux JP
Dakar Med; 2003; 48(3):202-5. PubMed ID: 15776632
[TBL] [Abstract][Full Text] [Related]
29. [Neonatal screening for sickle cell anemia: evaluation of a five-year experience in an area of northern Paris].
Ducrocq R; Benkerrou M; Brahimi L; Belloy M; Briard ML; Vilmer E; Elion J
Arch Pediatr; 2001 May; 8(5):474-80. PubMed ID: 11396106
[TBL] [Abstract][Full Text] [Related]
30. Starting neonatal screening for haemoglobinopathies in The Netherlands.
Giordano PC
J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
[TBL] [Abstract][Full Text] [Related]
31. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
[TBL] [Abstract][Full Text] [Related]
32. Sickle cell disease in the Caribbean: progress in newborn screening, clinical care, and research through collaboration.
Knight-Madden J; Asnani M; King L; Hardy-Dessources MD
Lancet Haematol; 2023 Aug; 10(8):e581-e582. PubMed ID: 37451303
[No Abstract] [Full Text] [Related]
33. [Sickle-cell disease: geographical distribution and population estimates].
Piel FB
Med Sci (Paris); 2013 Nov; 29(11):965-7. PubMed ID: 24280499
[No Abstract] [Full Text] [Related]
34. [Sickle cell disease in heel injection screening. II].
Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
[No Abstract] [Full Text] [Related]
35. Targeted screening failures in neonates with sickle cell disease in metropolitan France from 2005 to 2017: Number of cases, failure circumstances and health at diagnosis.
Remion J; Pluchart C
Arch Pediatr; 2019 Nov; 26(8):451-452. PubMed ID: 31685410
[No Abstract] [Full Text] [Related]
36. Capacity building and networking to make newborn screening for sickle cell disease a reality in Haiti.
Saint Fleur R; Archer N; Hustace T; Louis RJ; Bellevue R; Gautier J; Lerebours E; Voltaire M; Alvarez O
Blood Adv; 2018 Nov; 2(Suppl 1):54-55. PubMed ID: 30504202
[No Abstract] [Full Text] [Related]
37. [One year of neonatal screening for sickle-cell disease in Emma Children's Hospital/Academic Medical Center in Amsterdam].
Heijboer H; van den Tweel XW; Peters M; Knuist M; Prins J; Heymans HS
Ned Tijdschr Geneeskd; 2001 Sep; 145(37):1795-9. PubMed ID: 11582643
[TBL] [Abstract][Full Text] [Related]
38. [Sickle cell disease in heel injection screening. I].
Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H
Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863
[No Abstract] [Full Text] [Related]
39. Identifying homozygous sickle cell disease when neonatal screening is not available: a clinic-based observational study.
Hambleton IR; Wierenga KJ
J Med Screen; 2004; 11(4):175-9. PubMed ID: 15563773
[TBL] [Abstract][Full Text] [Related]
40. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
